<code id='FD50761E20'></code><style id='FD50761E20'></style>
    • <acronym id='FD50761E20'></acronym>
      <center id='FD50761E20'><center id='FD50761E20'><tfoot id='FD50761E20'></tfoot></center><abbr id='FD50761E20'><dir id='FD50761E20'><tfoot id='FD50761E20'></tfoot><noframes id='FD50761E20'>

    • <optgroup id='FD50761E20'><strike id='FD50761E20'><sup id='FD50761E20'></sup></strike><code id='FD50761E20'></code></optgroup>
        1. <b id='FD50761E20'><label id='FD50761E20'><select id='FD50761E20'><dt id='FD50761E20'><span id='FD50761E20'></span></dt></select></label></b><u id='FD50761E20'></u>
          <i id='FD50761E20'><strike id='FD50761E20'><tt id='FD50761E20'><pre id='FD50761E20'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:957
          A box of Sudafed PE sinus pressure and pain medicine. -- health coverage from stat
          PATRICK T. FALLON/AFP via Getty Images

          You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.

          Yet when T.J. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?”

          advertisement

          He had a point.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Readout Newsletter: Amgen, Regeneron, BGI Group and more
          Readout Newsletter: Amgen, Regeneron, BGI Group and more

          KristofferTripplaar/SipaviaAPWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup toget

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Global cancer cases to surge 77% by 2050, WHO report says

          MassGeneralCancerCenterThepredictionisdire:Cancercasesaroundtheworldareexpectedtosurge77%by2050,anew